The bill, known as the Jeff, Dave, and Angie Patient Right to Try Act, proposes the enactment of section 3792.08 of the Revised Code, which outlines the conditions under which prescribers can issue prescriptions for drugs, including off-label uses, provided they obtain informed consent from the patient or their personal representative. The bill defines key terms such as "health-related licensing board," "hospital," "in-house prescriber," and "off-label use," and establishes the responsibilities of prescribers and pharmacists in the prescription and dispensing process. It also includes provisions for patient rights regarding drug administration and the transfer of patients to other facilities if necessary.

Additionally, the bill stipulates that health-related licensing boards and state agencies cannot consider the actions of prescribing or dispensing drugs under this section as unlawful or unprofessional conduct, except in cases of recklessness or gross negligence. It emphasizes the protection of free speech for healthcare professionals regarding their opinions on drug safety and efficacy. However, the bill does not apply to existing laws concerning controlled substances, certain drugs subject to risk evaluation, and other specified categories, ensuring that those regulations remain intact.